Adaptimmune Therapeutics plc - American Depositary Shares (ADAP)
0.0513
-0.0077 (-13.05%)
NASDAQ · Last Trade: Oct 21st, 1:33 PM EDT
Detailed Quote
Previous Close
0.0590
Open
0.0479
Bid
0.0511
Ask
0.0515
Day's Range
0.0417 - 0.0550
52 Week Range
0.0403 - 0.8600
Volume
90,648,176
Market Cap
78.78M
PE Ratio (TTM)
-0.4664
EPS (TTM)
-0.1
Dividend & Yield
N/A (N/A)
1 Month Average Volume
107,629,170
Chart
About Adaptimmune Therapeutics plc - American Depositary Shares (ADAP)
Adaptimmune is a biotechnology company focused on developing T-cell therapy to treat cancer. The company specializes in harnessing the power of the immune system, particularly using engineered T-cell receptors (TCRs), to target and eliminate cancer cells more effectively. Adaptimmune’s innovative approach aims to improve patient outcomes in various cancers by personalizing therapies to the individual’s unique tumor characteristics. Through ongoing research and clinical trials, the company strives to bring transformative treatment options to patients suffering from life-threatening malignancies. Read More
Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top gainers and losers in today's session.
Curious to know what's happening on the US markets in the middle of the day on Monday? Join us as we explore the top gainers and losers in today's session.
Adaptimmune Therapeutics plc (NASDAQ: ADAP) has sent shockwaves through the biotechnology sector with its announcement on October 20, 2025, of a voluntary delisting of its American Depositary Shares (ADSs) from the Nasdaq Capital Market. The news triggered an immediate and dramatic 62.5% plunge in the company's stock during premarket
As we await the opening of the US market on Monday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Philadelphia, Pennsylvania and Oxford, United Kingdom--(Newsfile Corp. - October 20, 2025) - Adaptimmune Therapeutics plc (NASDAQ: ADAP) ("Adaptimmune" or the...
Stay updated with the latest market activity on Thursday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight.
